AI주식인사이트AI Stock Insight
B

CG인바이츠

083790KOSDAQ

55.4 / 100

Reference Date: 2026-09-08

Financial Score24.0 / 40
News Sentiment14.4 / 25
Momentum5.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CGinBites operates in pharmaceutical R&D, AI healthcare solutions, and thermal patch manufacturing, with key projects including the approved drug 'Acell克斯' and ongoing clinical trials for cancer treatments. The company leads medical innovation through precision medicine platforms based on genomic analysis and AI-driven digital healthcare solutions. It also contributes to ecosystem expansion via venture investments and startup support.

Number of Employees

92people

Average Salary

60.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.60Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-10.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
13.45Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲163.2% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲6.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -26.3% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 1Average Sentiment Score 57.5

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 925Won52-week high 1,88752-week low 744
1-month return2.0Point

1m -6.94% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0
  • Positive[기재정정]단일판매ㆍ공급계약체결2026-09-07
  • Neutral타인에대한담보제공결정2026-09-02
  • Neutral주식등의대량보유상황보고서(일반)2026-09-01
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral주주명부폐쇄기간또는기준일설정2026-08-14